Duke Health Joins with nference to Advance Medical Research and Patient Care
< Back to All Publications
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
Dec 2 2020
Longitudinal characterization of SARS-CoV-2 PCR testing from COVID-19 patient’s nasopharynx and its juxtaposition with blood-based IgG-seroconversion diagnostic assays is critical to understanding SARS-CoV-2 infection durations. Here, we retrospectively analyze 851 SARS-CoV-2-positive patients with at least two positive PCR tests and find that 99 of these patients remain SARS-CoV-2-positive after 4 weeks from their initial diagnosis date. For the 851-patient cohort, the mean lower bound of viral RNA shedding was 17.3 days (SD: 7.8), and the mean upper bound of viral RNA shedding from 668 patients transitioning to confirmed PCR-negative status was 22.7 days (SD: 11.8). Among 104 patients with an IgG test result, 90 patients were seropositive to date, with mean upper bound of time to seropositivity from initial diagnosis being 37.8 days (95% CI: 34.3–41.3). Our findings from juxtaposing IgG and PCR tests thus reveal that some SARS-CoV-2-positive patients are non-hospitalized and seropositive, yet actively shed viral RNA (14 of 90 patients). This study emphasizes the need for monitoring viral loads and neutralizing antibody titers in long-term non-hospitalized shedders as a means of characterizing the SARS-CoV-2 infection lifecycle.
Vineet Agarwal, AJ Venkatakrishnan, Arjun Puranik, Christian Kirkup, Agustin Lopez-Marquez, Douglas W Challener, Elitza S Theel, John C. O Horo, Matthew J Binnicke, Walter K Kremers, William A Faubion Jr, Andrew D. Badley, Amy W Williams, Gregory J Gores, John D. Halamka, William G. Morice II, Venky Soundararajan
nference, Cambridge, MA 02142 Mayo Clinic, Rochester, MN 55905 Mayo Clinic Laboratories, Rochester, MN 55905
Venky Soundararajan (email@example.com)
Let’s talk about how we can work together.
Fill out the form and we’ll get right back to you.